The Deal Register
Database › M&A › ESSA Pharma Inc., with XenoTherapeutics

M&A

ESSA Pharma Inc., with XenoTherapeutics

Lane
M&A
Announced
24 Sep 2025
Province
British Columbia
Industry
Healthcare & life sciences
Status
In court
Latest event
Court hearing scheduled
What the filing says
Special Meeting to Reconvene on October 3, 2025 In connection with the Amended Agreement, ESSA also announced today that it has further adjourned its special meeting of the holders of common shares of the Company ("Common Shares" and the holders of such Common Shares, the "Shareholders"), optionholders and warrantholders (the "Special Meeting") scheduled to occur on September 29, 2025 .
Source

The terms are in the subscriber edition

This transaction carries the date the proceeding opened and 2 officer and advisor credits.

Subscribe

Compiled from public filings, court documents, exchange bulletins and issuer releases. Figures are as disclosed and are not independently verified.

Not financial, investment, legal or tax advice, and not an offer to buy or sell any security. Verify everything before you transact.

The Deal Register · Archive · Subscribe